127 related articles for article (PubMed ID: 11128242)
1. Predictive performance study of two digoxin assays in subjects with various degrees of renal function.
Spinler SA; Al-Jazairi AS; Cheng JW; Kapoor S; Kobrin S; Shaw L
Ther Drug Monit; 2000 Dec; 22(6):729-36. PubMed ID: 11128242
[TBL] [Abstract][Full Text] [Related]
2. [False results of measuring digoxin levels in patients with renal failure. Comparison of the RIA--FPIA methods].
Jankowski A; Karwowski J; Marzec A; Kretowicz W; Nartowicz E
Kardiol Pol; 1990 Feb; 33(2):116-21. PubMed ID: 2277482
[TBL] [Abstract][Full Text] [Related]
3. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
[TBL] [Abstract][Full Text] [Related]
4. False-positive serum digoxin concentrations determined by three digoxin assays in patients with liver disease.
Frisolone J; Sylvia LM; Gelwan J; Pal S; Pellechia C
Clin Pharm; 1988 Jun; 7(6):444-9. PubMed ID: 3402179
[TBL] [Abstract][Full Text] [Related]
5. Intercomparison of seven radioimmunoassay kits and a fluorescence polarization immunoassay kit for digoxin.
Erickson KA; Green PJ
Clin Chem; 1984 Jul; 30(7):1225-7. PubMed ID: 6733904
[TBL] [Abstract][Full Text] [Related]
6. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients.
Schroeder TJ; Brunson ME; Pesce AJ; Hindenlang LL; Mauser PA; Ruckrigl DI; Weibel ML; Wadih G; First MR
Transplantation; 1989 Feb; 47(2):262-6. PubMed ID: 2645710
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of the Abbott TDx fluorescence polarization immunoassay analyzer.
Oeltgen PR; Shank WA; Blouin RA; Clark T
Ther Drug Monit; 1984; 6(3):360-7. PubMed ID: 6390799
[TBL] [Abstract][Full Text] [Related]
9. Effect of digoxin Fab antibodies on five digoxin immunoassays.
Ujhelyi MR; Cummings DM; Green P; Ellison MJ; Vlasses PH
Ther Drug Monit; 1990 May; 12(3):288-92. PubMed ID: 2349615
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactivity of TDX and OPUS immunoassay systems for serum digoxin determination.
Okazaki M; Tanigawara Y; Kita T; Komada F; Okumura K
Ther Drug Monit; 1997 Dec; 19(6):657-62. PubMed ID: 9421107
[TBL] [Abstract][Full Text] [Related]
11. Lack of apparent effect of assay methodology on the pharmacokinetics of digoxin.
Blum RA; DeVito JM; Pleasants RA; Crass RE; Gadsden RH; Leman RB
Ther Drug Monit; 1987 Dec; 9(4):416-21. PubMed ID: 3424407
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of digoxin concentrations determined by three assay systems: TDx, IMx and OPUS.
Kagawa Y; Iwamoto T; Matsuda H; Mukohara R; Sawada J; Kojima M
Biopharm Drug Dispos; 2004 Jan; 25(1):21-6. PubMed ID: 14716749
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the appropriateness of serum digoxin concentration measurement in a medical group setting.
Orrico KB; Wu M; Wilson AR
J Manag Care Pharm; 2011 Nov; 17(9):695-700. PubMed ID: 22050394
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-multiplied immunoassay (EMIT 2000) digoxin assay compared with fluorescence polarization immunoassay and amerlex 125I-radioimmunoassay at two Australian centers.
Saccoia NC; Hackett LP; Morris RG; Ilett KF
Ther Drug Monit; 1996 Dec; 18(6):672-7. PubMed ID: 8946664
[TBL] [Abstract][Full Text] [Related]
15. Analysis of digoxin concentrations in serum by fluorescence polarization immunoassay: an evaluation.
Ferreri LF; Raisys VA; Opheim KE
J Anal Toxicol; 1984; 8(3):138-40. PubMed ID: 6376949
[TBL] [Abstract][Full Text] [Related]
16. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
Mojaverian P; Green PJ; Jhangiania RK; Chase GD
J Pharm Biomed Anal; 1989; 7(5):585-92. PubMed ID: 2490762
[TBL] [Abstract][Full Text] [Related]
17. Quality of requests for serum digoxin concentrations: experience from an Australian regional health service.
Ellington C; Grgurinovich N; Miners JO; Mangoni AA
Br J Clin Pharmacol; 2007 May; 63(5):623-7. PubMed ID: 17073890
[TBL] [Abstract][Full Text] [Related]
18. Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids.
Steimer W; Müller C; Eber B
Clin Chem; 2002 Mar; 48(3):507-16. PubMed ID: 11861441
[TBL] [Abstract][Full Text] [Related]
19. Measuring endogenous digoxin-like substance and exogenous digoxin in the serum of low-birth-weight infants.
Ng PK; LeGatt D; Coates J; Collins-Nakai RL
Am J Hosp Pharm; 1985 Sep; 42(9):1977-9. PubMed ID: 3901741
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Abbott TDx fluorescence polarization immunoassay, Sandoz radioimmunoassay, and high-performance liquid chromatography methods for the assay of serum cyclosporine.
Schroeder TJ; Pesce AJ; Hassan FM; Wermeling JR; Warner A; Schlueter KT; First MR
Transplant Proc; 1988 Apr; 20(2 Suppl 2):345-7. PubMed ID: 3284078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
